← All trials
NCT04056117
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2019
- Primary completion
- Sep 30, 2021
- Completion date
- Jan 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 592
- Arms / groups
- 19 / —
- Source
- AACT · ingestion pipeline
Sponsors
- LimmaTech Biologics AGLead sponsor
- Kenya Medical Research InstituteCollaborator
- Wellcome TrustCollaborator
- Kenya Medical Research InstituteOverall official - principal investigator
- Wellcome TrustOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.